Search Results - "van Weezenbeek, C."

Healthcare workers with tuberculosis infected during work by de Vries, G, Sebek, M. M. G. G, Lambregts-van Weezenbeek, C. S. B

“…The risk for healthcare workers (HCWs) of tuberculosis (TB) attributable to occupational exposure is difficult to determine, as are the conditions contributing…”
Get full text

Multidrug resistance in new tuberculosis patients: burden and implications [Short communication] by Royce, S., Falzon, D., van Weezenbeek, C., Dara, M., Hyder, K., Hopewell, P., Richardson, M. D., Zignol, M.

“…In 2010, 30 countries with anti-tuberculosis drug resistance surveillance data were each estimated to have more than 700 multidrug-resistant tuberculosis…”
Get full text

Ending TB-related stigma and discrimination by Jaramillo, E., Sahu, S., Van Weezenbeek, C.

Get full text

Reduction of tuberculosis burden among prisoners in Mongolia: review of case notification, 2001-2010 [Notes from the field] by Yanjindulam, P., Oyuntsetseg, P., Sarantsetseg, B., Ganzaya, S., Amgalan, B., Narantuya, J., Nishikiori, N., Lambregts-van Weezenbeek, C.

“…Documentation on the TB situation in prisons in developing countries is limited, and very few studies have quantitatively evaluated TB control programmes in…”
Get full text

Global Incidence of Multidrug-Resistant Tuberculosis by Zignol, Matteo, Hosseini, Mehran S., Wright, Abigail, Weezenbeek, Catharina Lambregts–van, Nunn, Paul, Watt, Catherine J., Williams, Brian G., Dye, Christopher

“…BackgroundThe global number of incident cases of multidrug-resistant (MDR) tuberculosis (TB) in 2000 was estimated to be 272,906 (95% confidence interval [CI],…”
Get full text

Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997 by Pablos-Méndez, Ariel, Raviglione, Mario C, Laszlo, Adalbert, Binkin, Nancy, Rieder, Hans L, Bustreo, Flavia, Cohn, David L, Lambregts-van Weezenbeek, Catherina S.B, Kim, Sang Jae, Chaulet, Pierre, Nunn, Paul

“…In the past 50 years, the proliferation of antimicrobial agents for use in humans and animals has placed an unprecedented selective pressure on microorganisms…”
Get full text

Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: rates, risk factors and treatment outcome by LAMBREGTS-VAN WEEZENBEEK, C. S. B, JANSEN, H. M, NAGELKERKE, N. J. D, VAN KLINGEREN, B, VEEN, J

“…Setting: The Netherlands, 1993 and 1994.OBJECTIVE: To determine 1) rates of drug resistance in relation to nationality and country of birth, 2) risk factors…”
Get full text

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring by Lambregts-van Weezenbeek, C S B, Sebek, M M G G, van Gerven, P J H J, de Vries, G, Verver, S, Kalisvaart, N A, van Soolingen, D

“…SETTING: The Netherlands, 1995-2000.OBJECTIVES: To describe the contribution of 6 years of nationwide DNA fingerprint surveillance to tuberculosis control in…”
Get full text

Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands: the truth behind the rates by LAMBREGTS-VAN WEEZENBEEK, C. S. B, JANSEN, H. M, VEEN, J, NAGELKERKE, N. J. D, SEBEK, M. M. G. G, VAN SOOLINGEN, D

“…Setting: The Netherlands, May 1994 to May 1996.Objective: 1) To estimate to what extent drug-resistant tuberculosis was acquired or recently transmitted in The…”
Get full text

Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group by Schwoebel, V, Lambregts-van Weezenbeek, CS, Moro, ML, Drobniewski, F, Hoffner, SE, Raviglione, MC, Rieder, HL

“…Surveillance of antituberculosis drug resistance is an essential tool for evaluating the quality of tuberculosis control programmes. Consensus-based…”
Get full text

Market size and sales pattern of tuberculosis drugs in the Philippines by Islam, T., van Weezenbeek, C., Vianzon, R., Garfin, A. M. C. G., Hiatt, T., Lew, W. J., Tisocki, K.

“…OBJECTIVES: To identify the availability, types and quantity of anti-tuberculosis drugs in the public and private sectors from 2007 to 2011 in the…”
Get full text

Control of drug-resistant tuberculosis by Lambregts-van Weezenbeek, C.S.B., Veen, J.

“…Drug-resistant tuberculosis is a global problem, but the necessity and quality of intervention should be assessed by country since the causes of drug…”
Get full text

Ethambutol versus streptomycin during the hospitalized intensive phase of tuberculosis treatment in Benin by Gninafon, M., Lambregts-van Weezenbeek, C.S.B., Tawo, L., Trebucq, A.

Get full text

Standardization of antituberculosis drug resistance surveillance in Europe

Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group by Schwœbel, V., Lambregts‐van Weezenbeek, C.S.B., Moro, M‐L., Drobniewski, F, Hoffner, S.E, Raviglione, M.C, Rieder, H.L

“…Surveillance of antituberculosis drug resistance is an essential tool for evaluating the quality of tuberculosis control programmes. Consensus‐based…”
Get full text

A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB) [Consensus Statement] by Gupta, Rajesh, Espinal, Marcos

Get full text

The tuberculin skin test in the Netherlands: new policies for an old test; guideline from the Netherlands Tuberculosis Control Policy Committee by Lambregts-van Weezenbeek, C S B, Cobelens, F G J, Mensen, E A M

“…The primary function of tuberculin skintesting is to demonstrate latent tuberculosis infection. The Netherlands Tuberculosis Control Policy Committee revised…”
Get more information

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring: Tuberculosis contact investigations by LAMBREGTS-VAN WEEZENBEEK, C. S. B, SEBEK, M. M. G. G, VAN GERVEN, P. J. H. J, DE VRIES, G, VERVER, S, KALISVAART, N. A, VAN SOOLINGEN, D

Get full text

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring by Lambregts-van Weezenbeek, C S B, Sebek, M M G G, van Gerven, P J H J, de Vries, G, Verver, S, Kalisvaart, N A, van Soolingen, D

“…The Netherlands, 1995-2000. To describe the contribution of 6 years of nationwide DNA fingerprint surveillance to tuberculosis control in general and to…”
Get full text

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance by Pablos-Méndez, A, Raviglione, M C, Laszlo, A, Binkin, N, Rieder, H L, Bustreo, F, Cohn, D L, Lambregts-van Weezenbeek, C S, Kim, S J, Chaulet, P, Nunn, P

“…Drug-resistant tuberculosis threatens efforts to control the disease. This report describes the prevalence of resistance to four first-line drugs in 35…”
Get full text

Drug resistance in Mycobacterium tuberculosis in The Netherlands by Lambregts-van Weezenbeek, C S, van Klingeren, B, Veen, J

“…To determine magnitude, trend and specific features of the resistance problem. Descriptive. Royal Netherlands Tuberculosis Association, The Hague, the…”
Get more information